✦ LIBER ✦

The treatment of operable carcinoma of the breast

✍ Scribed by Thomas C. Case

Book ID: 118835273
Publisher: Elsevier Science
Year: 1957
Tongue: English
Weight: 657 KB
Volume: 94
Category: Article
ISSN: 0002-9610
DOI: 10.1016/0002-9610(57)90798-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

RESULTS OF OPERATIVE TREATMENT IN CARCIN

RESULTS OF OPERATIVE TREATMENT IN CARCINOMA OF THE BREAST

✍ Jessop, W.H.Graham 📂 Article 📅 1936 🏛 The Lancet 🌐 English ⚖ 503 KB

Current operative treatment of carcinoma

Current operative treatment of carcinoma of the breast and its rationale

✍ David Gold; Edgar J. Poth 📂 Article 📅 1965 🏛 Elsevier Science 🌐 English ⚖ 851 KB

The value of post-operative irradiation

The value of post-operative irradiation in the treatment of carcinoma of the breast

✍ Marcos W. Lederman; Salim Aisen; Wladimir Nadalin; Shalom Kalnicki 📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 83 KB

The early spread of breast carcinoma and

The early spread of breast carcinoma and its bearing on operative treatment

✍ R. S. Handley 📂 Article 📅 1964 🏛 John Wiley and Sons 🌐 English ⚖ 534 KB

Ten-year results of the treatment of pri

Ten-year results of the treatment of primary operable breast carcinoma. A summary of 304 patients evaluated by the TNM system

✍ David Schottenfeld; Anthony G. Nash; Guy F. Robbins; Edward J. Beattie Jr 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

Docetaxel plus epidoxorubicin as neoadju

Docetaxel plus epidoxorubicin as neoadjuvant treatment in patients with large operable or locally advanced carcinoma of the breast : A single-center, Phase II study

✍ Andrea de Matteis; Francesco Nuzzo; Giuseppe D'Aiuto; Vincenzo Labonia; Gabriell 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to test the activity and toxicity of epirubicin plus docetaxel as primary chemotherapy for women with large, operable (T2; > 3 cm) or locally advanced (Stage III) breast carcinoma, including patients with inflammatory breast carcinoma. ##